Administration guidelines for intraperitoneal chemotherapy for ovarian cancer

Deborah K. Armstrong

doi:10.1007/978-3-642-12130-2_8

Administration guidelines for intraperitoneal chemotherapy for ovarian cancer

Deborah K. Armstrong

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

Ovarian cancer has a unique pattern of spread, with the peritoneal cavity being the primary site of disease. Intraperitoneal delivery of chemotherapeutic agents allows for a higher concentration of drug for a more prolonged period of time at the major site of disease, providing a rationale for its use in ovarian cancer. This approach is supported by multiple clinical trials demonstrating an improved outcome for ovarian cancer patients who receive intraperitoneal chemotherapy. This chapter will address issues critical to the administration of intraperitoneal chemotherapy in ovarian cancer including selection of appropriate patients, the fundamentals of intraperitoneal chemotherapy administration, as well as practical guidelines for trouble-shooting commonly encountered problems.

Original language	English (US)
Title of host publication	Intraperitoneal Therapy for Ovarian Cancer
Publisher	Springer Berlin Heidelberg
Pages	89-94
Number of pages	6
ISBN (Print)	9783642121296
DOIs	https://doi.org/10.1007/978-3-642-12130-2_8
State	Published - Dec 1 2010

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-642-12130-2_8

Cite this

@inbook{b9d3229ad4074c3f939e47aee9412ca7,

title = "Administration guidelines for intraperitoneal chemotherapy for ovarian cancer",

abstract = "Ovarian cancer has a unique pattern of spread, with the peritoneal cavity being the primary site of disease. Intraperitoneal delivery of chemotherapeutic agents allows for a higher concentration of drug for a more prolonged period of time at the major site of disease, providing a rationale for its use in ovarian cancer. This approach is supported by multiple clinical trials demonstrating an improved outcome for ovarian cancer patients who receive intraperitoneal chemotherapy. This chapter will address issues critical to the administration of intraperitoneal chemotherapy in ovarian cancer including selection of appropriate patients, the fundamentals of intraperitoneal chemotherapy administration, as well as practical guidelines for trouble-shooting commonly encountered problems.",

author = "Armstrong, {Deborah K.}",

year = "2010",

month = dec,

day = "1",

doi = "10.1007/978-3-642-12130-2_8",

language = "English (US)",

isbn = "9783642121296",

pages = "89--94",

booktitle = "Intraperitoneal Therapy for Ovarian Cancer",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Administration guidelines for intraperitoneal chemotherapy for ovarian cancer

AU - Armstrong, Deborah K.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Ovarian cancer has a unique pattern of spread, with the peritoneal cavity being the primary site of disease. Intraperitoneal delivery of chemotherapeutic agents allows for a higher concentration of drug for a more prolonged period of time at the major site of disease, providing a rationale for its use in ovarian cancer. This approach is supported by multiple clinical trials demonstrating an improved outcome for ovarian cancer patients who receive intraperitoneal chemotherapy. This chapter will address issues critical to the administration of intraperitoneal chemotherapy in ovarian cancer including selection of appropriate patients, the fundamentals of intraperitoneal chemotherapy administration, as well as practical guidelines for trouble-shooting commonly encountered problems.

AB - Ovarian cancer has a unique pattern of spread, with the peritoneal cavity being the primary site of disease. Intraperitoneal delivery of chemotherapeutic agents allows for a higher concentration of drug for a more prolonged period of time at the major site of disease, providing a rationale for its use in ovarian cancer. This approach is supported by multiple clinical trials demonstrating an improved outcome for ovarian cancer patients who receive intraperitoneal chemotherapy. This chapter will address issues critical to the administration of intraperitoneal chemotherapy in ovarian cancer including selection of appropriate patients, the fundamentals of intraperitoneal chemotherapy administration, as well as practical guidelines for trouble-shooting commonly encountered problems.

UR - http://www.scopus.com/inward/record.url?scp=84895334922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895334922&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-12130-2_8

DO - 10.1007/978-3-642-12130-2_8

M3 - Chapter

AN - SCOPUS:84895334922

SN - 9783642121296

SP - 89

EP - 94

BT - Intraperitoneal Therapy for Ovarian Cancer

PB - Springer Berlin Heidelberg

ER -

Administration guidelines for intraperitoneal chemotherapy for ovarian cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this